• 🌎 Worldwide
    • πŸ‡ΊπŸ‡Έ U.S.
    • πŸ‡¨πŸ‡¦ Canada
    • πŸ‡¬πŸ‡§ United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • πŸ”’ PRO
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • πŸ”’ PRO
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Health

MMJ Files FDA Fast Track Approval Application For Cannabis Multiple Sclerosis Drug

PRWeb by PRWeb
February 13, 2019
in Doctors, Health, Press Releases, United States
FDA Cannabis and CBD News

Photo Credit - The U.S. Food and Drug Administration

143
SHARES
ShareShare

RESTON, VA. (PRWEB) FEBRUARY 13, 2019 – MMJ International Holdings, the premier medical cannabis research company, is advancing the science of medical marijuana legally through patient clinical trials and research, announced that it is seeking fast track designation approval from the FDA.

The FDA grants Fast Track Designation to help expedite the review and approval of drugs in development that treat serious or life threatening diseases and fill patients unmet medical needs. MMJ-001 the companies new cannabis based pharmaceutical drug for multiple sclerosis will show robust treatment results.

The MMJ Group is focused on collaborative scientific research projects that follows the FDA guidelines. MMJ will conduct its clinical trials to fully explore the potential of cannabis medicine for progressive Multiple Sclerosis and Huntington’s patients.

Bianca Weinstock-Guttman MD, MMJ International Holding’s principal investigator is a widely known leading expert on multiple sclerosis (MS) in adults and children. She also is a Professor of Neurology at the State University of New York at Buffalo who serves as Executive Director of the New York State Multiple Sclerosis Consortium. Dr. Weinstock-Guttman will oversee the FDA approved study exploring the potential therapeutic applications of cannabinoids for progressive multiple sclerosis patients.

MMJ International Holdings will begin a first “dose ranging” study comparing its pharmaceutical formulation of THC and CBD to placebo. It is expected that the study will demonstrate acceptable tolerable patient doses of the medicine.

Duane Boise the company’s CEO stated, “The positive data from this dosing study is important in that it will provide us with the necessary evidence on patient tolerance to different doses of THC and CBD for the treatment for PPMS. This information will prove value to assist clinicians with prescribing decisions to address individual patient needs should this medicine be FDA approved for use.”

MMJ International Holdings team continues to evaluate numerous plant derived cannabinoid medicines and currently has several planned clinical trials including Huntington’s disease. MMJ International Holdings will be one of the world’s first natural plant-derived cannabinoid prescription drugs once approved by the FDA for the treatment of spasticity and pain due to multiple sclerosis. For further information, please visit http://www.mmjih.com

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: MMJ International Holdings Corp.multiple sclerosisU.S. Food and Drug Administration

Get Real-Time Updates from MJobserver.com

Unsubscribe
PRWeb

PRWeb

​PRWeb’s industry-leading distribution network shares your story to targeted media websites, industry publications, blogs, social networks and search engines.

Related Posts

Marinol Dronabinol THC Pharmaceutical
Events

30+ Expert Speakers to Present at the 3rd Annual Cannabinoid-Derived Pharmaceuticals Summit

July 9, 2020
FDA Cannabis and CBD News
Press Releases

Charlotte’s Web Steps Up to Support Research to Address FDA’s Request for More Scientific Data

June 9, 2020
Submitting a Comment to the FDA on CBD in Foods and Beverages
Health

Tetra Receives its 4th FDA Orphan Drug Designation

April 16, 2020
New York City CBD Food and Drink Ban
New York City

Here’s What NYC Businesses Need to Know About the CBD Food Ban

July 12, 2019
Lowell Schiller from the FDA to Speak at Industrial Hemp Event
Events

Food and Drug Administration to Speak at National Industrial Hemp Council 2019 Hemp Business Summit

July 11, 2019
NYC Bans CBD-Infused Foods and Beverages
New York City

Emerald Organic Products CEO Not Worried About NYC Ban on CBD-Infused Foods

July 10, 2019
Load More
Next Post
Marijuana Stocks - Losers

5 of Today’s Biggest Marijuana Stock Losers - Wednesday, February 13, 2019

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

πŸ“° Recent News

  • CBD Vaping: Why So Many People Have Started
  • What Will Happen with Hemp 10 Years from Now?
  • MediPharm Labs Ships Company Record 550,000 Units in Q4 2020
  • Future Farm Provides Update on Fiscal Year 2020 Audit and Strategic Direction
  • CBD And The Rise Of The Wellness CafΓ©
Facebook Twitter Instagram LinkedIn Youtube

DMO PRO Subscription

  • πŸ“Š Free vs. Pro
  • πŸ“« Register
  • πŸ‘€ My Account
  • πŸ’³ Payment History
  • πŸ”‘ Recover Password
  • πŸ”“ Login
  • πŸ”’ Logout

Cannabis News by Region

  • πŸ‡ΊπŸ‡Έ United States
  • πŸ‡¨πŸ‡¦ Canada
  • πŸ‡¬πŸ‡§ United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • πŸ“… Calendar
  • πŸ“Š Databases
  • πŸ“‡ Directories
  • πŸ“™ Glossary
  • πŸ”” RSS Feeds
  • πŸ“Ί Videos

Find Cannabis Business Services

  • βš–οΈ Attorneys & Law Firms
  • πŸ“Š Accountants & Accounting Firms
  • πŸ’‘ Consultants & Consulting Firms
  • πŸ“² Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • πŸ‘€ Advertise
  • πŸ“£ DMO Newswire
  • πŸ“‡ List in Our Databases

Β© 2018 - 2020 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • πŸ”’ PRO
    • πŸ”’ A.M. Watchlist
    • πŸ”’ Analyst Action
  • πŸ’Ό Business
  • πŸ“ˆ Investments
    • πŸ“ˆ Stocks
    • πŸ’° ETFs and Funds
    • πŸ’­ Market Commentary
    • πŸ“° Press Releases
    • πŸ“… Earnings Calendar
  • βš–οΈ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • πŸ‘₯ People
    • ⚽ Athletes
    • πŸ’Ό Executives
    • 🌟 Celebrities
    • πŸ›’ Consumers
    • βš•οΈ Doctors
    • πŸ’Š Patients
  • πŸ’Š Health
  • πŸ“‡ Databases
    • πŸ“ˆ Stock Databases
    • πŸ’° Fund Databases
    • πŸ’Ό Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • πŸ’² Marijuana Cryptocurrencies

Β© 2018 - 2020 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.